help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spiro, S. G.
Right arrow Articles by Porter, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spiro, S. G.
Right arrow Articles by Porter, J. C.
American Journal of Respiratory and Critical Care Medicine Vol 166. pp. 1166-1196, (2002)
© 2002 American Thoracic Society

STATE OF THE ART

Lung Cancer—Where Are We Today?

Current Advances in Staging and Nonsurgical Treatment

Stephen G. Spiro and Joanna C. Porter

Department of Respiratory Medicine, University College, London Hospitals National Health Service Trust, London, United Kingdom

Correspondence and requests for reprints should be addressed to S. G. Spiro, M.D., F.R.C.P., Department of Thoracic Medicine, The Middlesex Hospital, Mortimer Street, London W1N 8AA, UK. E-mail: stephen.spiro{at}uclh.org

Lung cancer remains the commonest cause of cancer death in both men and women in the developed world, although mortality rates for men are dropping. Spiral computed tomography (CT) of the chest in middle-aged, smoking subjects may identify two to four times more lung cancers than a chest X-ray, with more than 70% of tumors being Stage I. The incidence of benign nodules is high, making interpretation difficult. Randomized controlled trials are required to determine whether spiral CT detects lung cancer early enough to improve mortality. Preoperative staging has relied on CT scans, but positron emission tomography scanning has greater sensitivity, specificity, and accuracy than CT and is recommended as the final confirmatory investigation when the CT shows resectable disease. In locally advanced non–small cell lung cancer, there is a small advantage for the addition of chemotherapy to radiotherapy, but no advantage for postoperative radiotherapy. Chemotherapy gives no benefit when given as neoadjuvant or adjuvant treatment around surgery. In advanced disease, newer cytotoxic agents confer a small survival advantage over older combinations, but the advantage in median survival over best supportive care remains a few months with modest improvements in quality of life. Survival with small cell lung cancer has shown little increase over the last 15 years despite multiple attempts to manipulate the timing, dose intensity of chemotherapy, and the potential of radiotherapy. Novel therapies are urgently needed for all cell types of lung cancer.

Key Words: chemotherapy • lung cancer • radiotherapy • screening • staging




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
J. P. Wisnivesky, E. Halm, M. Bonomi, C. Powell, and E. Bagiella
Effectiveness of Radiation Therapy for Elderly Patients with Unresected Stage I and II Non-Small Cell Lung Cancer
Am. J. Respir. Crit. Care Med., February 1, 2010; 181(3): 264 - 269.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
S. KATSIMPOULA, M. PATRINOU-GEORGOULA, N. MAKRILIA, K. DIMAKOU, A. GUIALIS, D. ORFANIDOU, and K.N. SYRIGOS
Overexpression of hnRNPA2/B1 in Bronchoscopic Specimens: A Potential Early Detection Marker in Lung Cancer
Anticancer Res, April 1, 2009; 29(4): 1373 - 1382.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
C von Plessen, T-E Strand, T Wentzel-Larsen, E Omenaas, N Wilking, S Sundstrom, and S Sorenson
Effectiveness of third-generation chemotherapy on the survival of patients with advanced non-small cell lung cancer in Norway: a national study
Thorax, October 1, 2008; 63(10): 866 - 871.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck
Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 178S - 201S.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
C. Nahmias, W. T. Hanna, L. M. Wahl, M. J. Long, K. F. Hubner, and D. W. Townsend
Time Course of Early Response to Chemotherapy in Non-Small Cell Lung Cancer Patients with 18F-FDG PET/CT
J. Nucl. Med., May 1, 2007; 48(5): 744 - 751.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Kobayashi, H. Kubo, T. Suzuki, K. Ishizawa, M. Yamada, M. He, Y. Yamamoto, H. Yamamoto, H. Sasano, H. Sasaki, et al.
Endogenous Secretory Receptor for Advanced Glycation End Products in Non-Small Cell Lung Carcinoma
Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 184 - 189.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. Yasufuku, T. Nakajima, K. Motoori, Y. Sekine, K. Shibuya, K. Hiroshima, and T. Fujisawa
Comparison of Endobronchial Ultrasound, Positron Emission Tomography, and CT for Lymph Node Staging of Lung Cancer.
Chest, September 1, 2006; 130(3): 710 - 718.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
T. C. McLoud
"A system for the clinical staging of lung cancer"--a commentary.
Am. J. Roentgenol., August 1, 2006; 187(2): 269 - 270.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Rossi, R. Dore, A. Cascina, V. Vespro, F. Garbagnati, L. Rosa, V. Ravetta, A. Azzaretti, P. Di Tolla, G. Orlandoni, et al.
Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours.
Eur. Respir. J., March 1, 2006; 27(3): 556 - 563.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. Paone, E. Nicastri, G. Lucantoni, R. Dello Iacono, P. Battistoni, A. L. D'Angeli, and G. Galluccio
Endobronchial Ultrasound-Driven Biopsy in the Diagnosis of Peripheral Lung Lesions
Chest, November 1, 2005; 128(5): 3551 - 3557.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J-E C Holty, W G Kuschner, and M K Gould
Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis
Thorax, November 1, 2005; 60(11): 949 - 955.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. P. Wisnivesky, M. Bonomi, C. Henschke, M. Iannuzzi, and T. McGinn
Radiation Therapy for the Treatment of Unresected Stage I-II Non-small Cell Lung Cancer
Chest, September 1, 2005; 128(3): 1461 - 1467.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. T. Annema, M. I. Versteegh, M. Veselic, L. Welker, T. Mauad, J. K. Sont, L. N. A. Willems, and K. F. Rabe
Endoscopic Ultrasound Added to Mediastinoscopy for Preoperative Staging of Patients With Lung Cancer
JAMA, August 24, 2005; 294(8): 931 - 936.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. P. Wisnivesky, T. McGinn, C. Henschke, P. Hebert, M. C. Iannuzzi, and E. A. Halm
Ethnic Disparities in the Treatment of Stage I Non-Small Cell Lung Cancer
Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1158 - 1163.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. P. Massion, P. M. Taflan, Y. Shyr, S. M. J. Rahman, P. Yildiz, B. Shakthour, M. E. Edgerton, M. Ninan, J. J. Andersen, and A. L. Gonzalez
Early Involvement of the Phosphatidylinositol 3-Kinase/Akt Pathway in Lung Cancer Progression
Am. J. Respir. Crit. Care Med., November 15, 2004; 170(10): 1088 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. de Perrot, S. Chernenko, T. K. Waddell, Y. Shargall, A. F. Pierre, M. Hutcheon, and S. Keshavjee
Role of Lung Transplantation in the Treatment of Bronchogenic Carcinomas for Patients With End-Stage Pulmonary Disease
J. Clin. Oncol., November 1, 2004; 22(21): 4351 - 4356.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. H. Kim, G. Ishii, K. Goto, K. Nagai, K. Tsuta, S. Shiono, J. Nitadori, T. Kodama, Y. Nishiwaki, and A. Ochiai
Dominant Papillary Subtype Is a Significant Predictor of the Response to Gefitinib in Adenocarcinoma of the Lung
Clin. Cancer Res., November 1, 2004; 10(21): 7311 - 7317.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. C. Borczuk, L. Shah, G. D. N. Pearson, K. L. Walter, L. Wang, J. H. M. Austin, R. A. Friedman, and C. A. Powell
Molecular Signatures in Biopsy Specimens of Lung Cancer
Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 167 - 174.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Fritscher-Ravens, B. L. Davidson, H.-P. Hauber, K. H. Bohuslavizki, C. Bobrowski, C. Lund, W. T. Knofel, N. Soehendra, L. Brandt, M. S. Pepe, et al.
Endoscopic Ultrasound, Positron Emission Tomography, and Computerized Tomography for Lung Cancer
Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1293 - 1297.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Writing a Review Article for AJRCCM
Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 732 - 734.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. M. la Cour, J. Mollerup, P. Winding, S. Tarabykina, M. Sehested, and M. W. Berchtold
Up-Regulation of ALG-2 in Hepatomas and Lung Cancer Tissue
Am. J. Pathol., July 1, 2003; 163(1): 81 - 89.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 356 - 370.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society 		  Mastering Teaching Skills in Pulm & Crit Care Med